It has been demonstrated that IDO2 knockout inhibits the production of autoantibodies and alleviates symptoms in arthritis models, suggesting that IDO2 acts as a pro-inflammatory mediator directly within B cells, while IDO1 has markedly different functions [61]. This evidence concerns the gene IDO2 and arthritic joint disease.